Evaluation of topical α-2 agonist in the treatment of mixed diabetic maculopathy
Purpose To evaluate the efficacy of topical α-2 agonist (brimonidine) in the treatment of mixed diabetic maculopathy (with edema and ischemia). Design This is a prospective randomized case series. Patients and methods Thirty eyes of 30 patients were included in this study. All eyes had mixed diabeti...
Main Authors: | Basem M Ibrahim, Haitham Y Al-Nashar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Delta Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.djo.eg.net/article.asp?issn=1110-9173;year=2018;volume=19;issue=2;spage=134;epage=139;aulast=Ibrahim |
Similar Items
-
Exudative Diabetic Maculopathy Treated By Frequancy Doubled Nd: Yag Laser (532nm)
by: Najah K. M. AL Quriashi
Published: (2007-04-01) -
Efficacy of topical dorzolamide 2% in diabetic cystoid macular edema
by: Amani E Badawi, et al.
Published: (2021-09-01) -
Acute hypotony maculopathy following the initiation of a topical aqueous suppressant in a patient with a history of panuveitis without prior filtering surgery
by: Dagny Zhu, et al.
Published: (2017-09-01) -
Surgical cystotomy for refractory diabetic cystoid macular edema
by: Tripathy K
Published: (2018-01-01) -
Effect of intravitreal dexamethasone implant on the contralateral eye in recalcitrant radiation maculopathy
by: Srishti Kamalmani Gulati, et al.
Published: (2019-01-01)